Dr. med. Ilka FuchsPD Dr. med. Ilka Fuchs

Fachärztin für Frauenheilkunde und Geburtshilfe mit den Schwerpunkten spezielle Geburtsmedizin und Perinatologie

Beruflicher Werdegang

  • seit 2008
    Fachärztin mit Zusatzqualifikation: spezielle Geburtsmedizin und Perinatalmedizin
  • 2008
    Abschluss Habilitation
  • seit 2005
    Fachärztin für Frauenheilkunde und Geburtshilfe
  • 2005
    DEGUM II

Stipendien und Preise

  • 2000 - 2002
    Forschungsförderung der deutschen Krebshilfe
  • 2001
    Rahel-Hirsch-Stipendium der Humboldt Universität Berlin
  • 1995
    „Johann-Georg-Zimmermann-Preis für Krebsforschung 1994/5“

Publikationsverzeichnis

Neuere Publikationen siehe unter www.researchgate.net
Ilka Fuchs oder
Center for penatal diagnosis and human genetics kudamm-199

  1. Blasi I, Fuchs I, D’Amico R, Vinci V, La Sala GB, Mazza V, Henrich W.
    Intrapartum translabial three-dimensional ultrasound visualization of levator trauma.
    Ultrasound Obstet Gynecol. 2011 Jan;37(1):88-92. PubMed PMID: 20814872.
  2. Blasi I, D’Amico R, Fenu V, Volpe A, Fuchs I, Henrich W, Mazza V.
    Sonographic assessment of fetal spine and head position during the first and second stages of labor for the diagnosis of persistent occiput posterior position: a pilot study.
    Ultrasound Obstet Gynecol. 2010 Feb;35(2):210-5. PubMed PMID: 20101635.
  3. Kuemmel S, Thomas A, Landt S, Fuger A, Schmid P, Kriner M, Blohmer JU, Sehouli J, Schaller G, Lichtenegger W, Köninger A, Fuchs I.
    Circulating vascular endothelial growth factors and their soluble receptors in pre-invasive, invasive and recurrent cervical cancer.
    Anticancer Res. 2009 Feb;29:641-5.
  4. Schaller G / Fuchs I (Equal contribution), Gonsch T, Weber T, Kleine-Tebbe A, Conrad B, Klare P, Hindenburg HJ, Ruhmland B, Lakner V, Hinke A, Bangemann N.
    Phase II Study with Capecitabine and Trastuzumab in HER2-overexpressing Metastatic Breast Cancer pretreated with Anthracyclines and/or Taxanes.
    J Clin Oncol. 2007; 25:3246-50.
  5. Fuchs I, Vorsteher N, Sehouli S., Bühler H., Evers K., Schaller G., Kuemmel S.
    The prognostic significance of the human epidermal growth factor receptor correlations in squamous cell carcinoma of the cervix.
    Anticancer Res. 2007;27:959-63.
  6. Fuchs I, Muller H, Abdul-Khaliq H, Harder T, Dudenhausen JW, Henrich W.
    Immediate and long-term outcomes in children with prenatal diagnosis of selected isolated congenital heart defects.
    Ultrasound Obstet Gynecol. 2007;29:38-43.
  7. Fuchs I, Siemer I, Buehler H, Schmider A, Henrich W, Lichtenegger W,Schaller G, Kuemmel S.
    Epidermal growth factor receptor changes during breast cancer metastasis.
    Anticancer Res. 2006;26:4397-401.
  8. Henrich W, Dudenhausen J, Fuchs I, Kamena A, Tutschek B.
    Intrapartum translabial ultrasound (ITU): sonographic landmarks and correlation with successful vacuum extraction.
    Ultrasound Obstet Gynecol. 2006;28:753-60.
  9. Tsoi E, Fuchs I, Rane S, Geerts L, Nicolaides KH.
    Sonographic measurement of cervical length in threatened preterm labor in singleton pregnancies with intact membranes.
    Ultrasound Obstet Gynecol. 2005;25:353-6.
  10. Buhling KJ, Fuchs I, Dudenhausen JW.
    Ultrasound finding and operative management of a uterine rupture during vaginal delivery after Cesarean section.
    Ultrasound Obstet Gynecol. 2005;25:203-5.
  11. Henrich W, Tutschek B, Buhling KJ, Fuchs I, Dudenhausen JW.
    Ultrasound finding and operative management of a uterine rupture during vaginal delivery after Cesarean section.
    Ultrasound Obstet Gynecol. 2005;25:203-5.
  12. Fuchs I, Henrich W, Osthues K, Dudenhausen JW.
    Sonographic cervical length in singleton pregnancies with intact membranes presenting with threatened preterm labor.
    Ultrasound Obstet Gynecol. 2004;24:554-7.
  13. Fuchs I, Tsoi E, Henrich W, Dudenhausen JW, Nicolaides KH.
    Sonographic measurement of cervical length in twin pregnancies in threatened preterm labor.
    Ultrasound Obstet Gynecol. 2004;23:42-5.
  14. Fuchs I, Henrich W, Kalache KD, Lippek F, Dudenhausen JW.
    Prenatal sonographic features of a rhabdoid tumor of the kidney.
    Ultrasound Obstet Gynecol. 2004;23:407-10.
  15. Tsoi E, Fuchs I, Henrich W, Dudenhausen JW, Nicolaides KH.
    Sonographic measurement of cervical length in preterm prelabor amniorrhexis.
    Ultrasound Obstet Gynecol. 2004;24:550-3.
  16. Henrich W, Fuchs I, Buhrer C, van Landeghem FK, Albig M, Stoever B, Dudenhausen JW.
    Isolated cardiomegaly in the second trimester as an early sign of fetal hydrops due to intracranial arteriovenous malformation.
    J Clin Ultrasound. 2003 Oct;31(8):445-9. Erratum in: J Clin Ultrasound. 2004 ;32:50-1.
  17. Fuchs I, Landt S, Buehler H, Kuehl U, Coupland S, Kleine-Tebbe A, Lichtenegger W, Schaller G.
    Analysis of HER2 and HER4 in human myocardium to clarify the cardiotoxicity of trastuzumab (Herceptin).
    Breast Cancer Res Treat. 2003;82:23-8.
  18. Fuchs I, Henrich W, Brauer M, Stover B, Guschmann M, Degenhardt P, Dudenhausen JW.
    Prenatal diagnosis of congenital mesoblastic nephroma in 2 siblings.
    J Ultrasound Med. 2003;22:823-7; quiz 828-9.
  19. Fuchs I, Henrich W, Schmider A, Lichtenegger W.
    Endometriotic cyst after subtotal abdominal hysterectomy mimicking carcinoma of the cervical stump.
    British Journal Obstet. Gynecol. 2003;110:637-8.
  20. Henrich W, Schmider A, Fuchs I, Schmidt F, Dudenhausen JW.
    The effects of working conditions and antenatal leave for the risk of premature birth in Berlin.
    Arch Gynecol Obstet. 2003;269:37-9.
  21. Fuchs I, Lichtenegger W, Buehler H, Henrich W, Stein H, Kleine-Tebbe A, Schaller G.
    The prognostic significance of epithelial-mesenchymal transition in breast cancer.
    Anticancer Res. 2002;22:3415-9.
  22. Fuchs I, Loebbecke M, Buhler H, Stoltenburg-Didinger G, Heine B,Lichtenegger W, Schaller G.
    HER2 in brain metastases: issues of concordance, survival, and treatment.
    J Clin Oncol. 2002;20:4130-3.
  23. Henrich W, Fuchs I, Schmider A, Buhling KJ, Dudenhausen JW.
    Transvaginal and transabdominal extended field-of-view (EFOV) and power Doppler EFOV sonography in gynecology: advantages and applications.
    J Ultrasound Med. 2002;21:1137-44.
  24. Henrich W, Fuchs I, Luttkus A, Hauptmann S, Dudenhausen JW.
    Pseudoaneurysm of the uterine artery after cesarean delivery: sonographic diagnosis and treatment.
    J Ultrasound Med. 2002;21:1431-4.
  25. Henrich W, Fuchs I, Ehrenstein T, Kjos S, Schmider A, Dudenhausen JW.
    Antenatal diagnosis of placenta percreta with planned in situ retention and methotrexate therapy in a woman infected with HIV.
    Ultrasound Obstet Gynecol. 2002;20:90-3.
  26. Fuchs I, Bühler H, Lichtenegger W, Schaller G.
    Die Bedeutung von Intermediärfilamentveränderungen für die Metastasierung und die Prognose des Mammakarzinoms.
    Geburtshilfe Frauenheilkunde 2001;61:112-116.
  27. Schaller G, Fuchs I, Ebert A, Gstettenbauer M, Herbst H, Lengyel E.
    [The clinical importance of keratin 18 in breast cancer]
    Zentralbl Gynakol. 1999;121:126-30.
  28. Schaller G, Fuchs I, Pritze W, Ebert A, Herbst H, Pantel K, Weitzel H, Lengyel E.
    Elevated keratin 18 protein expression indicates a favorable prognosis in patients with breast cancer.
    Clin Cancer Res. 1996;2:1879-85.

Übersichtsarbeiten

  • Fuchs I, Dudenhausen JW, Henrich W.
    Zervixsonographie: Bedeutung in der Schwangerschaft, gynäl prax 2007, 31, 437-446

Buchkapitel

  • In G. Schaller, Antikörpertherapie des Mammakarzinoms, Uni-Med-Verlag Bremen, 2002, ISBN3-89599-597-5
    Onkologie: Freiburg, 6.-8. Juli 1995

Praxispublikationen →